What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia

Hagop M. Kantarjian

doi:10.1038/s41375-023-02053-1

What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia

Hagop M. Kantarjian

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2324-2325
Number of pages	2
Journal	Leukemia
Volume	37
Issue number	11
DOIs	https://doi.org/10.1038/s41375-023-02053-1
State	Published - Nov 2023

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-023-02053-1

Cite this

@article{d331b0d42d294af1b5d57ab788529856,

title = "What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia",

author = "Kantarjian, {Hagop M.}",

year = "2023",

month = nov,

doi = "10.1038/s41375-023-02053-1",

language = "English (US)",

volume = "37",

pages = "2324--2325",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia

AU - Kantarjian, Hagop M.

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85173778680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85173778680&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-02053-1

DO - 10.1038/s41375-023-02053-1

M3 - Comment/debate

C2 - 37798329

AN - SCOPUS:85173778680

SN - 0887-6924

VL - 37

SP - 2324

EP - 2325

JO - Leukemia

JF - Leukemia

IS - 11

ER -

What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this